Publication: Paracrine Adenoviral Delivery of Therapeutic Payloads for Cancer Therapy
Paracrine Adenoviral Delivery of Therapeutic Payloads for Cancer Therapy
Date
Date
Date
Citations
Hartmann, K. P. (2024). Paracrine Adenoviral Delivery of Therapeutic Payloads for Cancer Therapy. (Dissertation, University of Zurich) https://doi.org/10.5167/uzh-258797
Abstract
Abstract
Abstract
Adenoviral vectors are the most commonly used delivery vectors for clinical gene therapy due to their favorable characteristics: (i) they do not integrate into the host cell genome and thus harbor a reduced risk of insertional mutagenesis, (ii) they efficiently transduce dividing and non-dividing cells, and (iii) they have a large packaging capacity allowing large and/or multiple cargo delivery. However, site-specific gene delivery in vivo is still compromised because of the endogenous adenoviral tropism and interactions with the host
Additional indexing
Creators (Authors)
Faculty
Faculty
Faculty
Item Type
Item Type
Item Type
Referees
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Dewey Decimal Classifikation
Language
Language
Language
Place of Publication
Place of Publication
Place of Publication
Publication date
Publication date
Publication date
Date available
Date available
Date available
Number of pages
Number of pages
Number of pages
OA Status
OA Status
OA Status
Citations
Hartmann, K. P. (2024). Paracrine Adenoviral Delivery of Therapeutic Payloads for Cancer Therapy. (Dissertation, University of Zurich) https://doi.org/10.5167/uzh-258797